Welcome to CDC Stacks | Interferon-gamma release assays (IGRAs) - blood tests for TB infection - 21966 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Interferon-gamma release assays (IGRAs) - blood tests for TB infection
  • Published Date:
    November, 2011
  • Language:
    English
Filetype[PDF - 179.62 KB]


Details:
  • Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
  • Keywords:
  • Description:
    What are they? -- How do they work? -- What are the advantages of IGRAs? -- What are the disadvantages and limitations of IGRAs? -- What are the steps in administering an IGRA test? -- How do you interpret IGRA test results? -- Recommendations on when to use IGRA tests -- Can IGRAs be given to persons receiving vaccinations? -- Additional information.

    Interferon-Gamma Release Assays (IGRAs) are whole-blood tests that can aid in diagnosing Mycobacterium tuberculosis infection. They do not help differentiate latent tuberculosis infection (LTBI) from tuberculosis disease. Two IGRAs that have been approved by the U.S. Food and Drug Administration (FDA) are commercially available in the U.S: QuantiFERON®-TB Gold In-Tube test (QFT-GIT); T-SPOT®.TB test (T-Spot).

  • Document Type:
    Pamphlet (or booklet)
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium Tuberculosis Infection - United States, 2010
    Corporate Author:
    Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, CDC, Atlanta, GA 30333, USA.
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2010; 59(RR-5):1-25.
    Description:
    An estimated one third of the world's population is infected with Mycobacterium tuberculosis, and nearly 9 million persons develop disease caused by M. tuberculosis each year. Although tuberculosis (TB) occurs predominantly in resource-limited countr...
    Status:
    current
    File Type:
    Filetype[PDF - 501.08 KB]
  2. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection -- United States, 2010
    Personal Author:
    Castro, Kenneth G.; Goldberg, Stefan; Jereb, John A.; LoBue, Philip.; Mazurek, Gerald H.; Vernon, Andrew;
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.; Centers for Disease Control and Prevention (U.S.); HIV Medicine Association; Infectious Diseases Society of America; National Institutes of Health (U.S.);
    Published:
    June 25, 2010
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 59, no. RR-5
    Description:
    "This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections (OIs) in HIV-infected adults (i.e., persons aged [more than or equal to] 18 years) and adolescents (i.e., persons aged 13--1...
    File Type:
    Filetype[PDF - 501.08 KB]
  3. Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants
    Personal Author:
    Chuke, Stella O.; Yen, Nguyen Thi Ngoc; Laserson, Kayla F.; Phuoc, Nguyen Huu; Trinh, Nguyen An; Nhung, Duong Thi Cam; Mai, Vo Thi Chi; Qui, An Dang; Hai, Hoang Hoa; Loan, Le Thien Huong; Jones, Warren G.; Whitworth, William C.; Shah, J. Jina; Painter, John A.; Mazurek, Gerald H.; Maloney, Susan A.;
    Published:
    Mar 06 2014
    Source:
    Tuberc Res Treat. 2014; 2014.
    Description:
    Objective. Use of tuberculin skin tests (TSTs) and interferon gamma release assays (IGRAs) as part of tuberculosis (TB) screening among immigrants from high TB-burden countries has not been fully evaluated. Methods. Prevalence of Mycobacterium tuberc...
    File Type:
    Filetype[PDF - 620.77 KB]
  4. Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests
    Personal Author:
    Powell, Richard D.; Whitworth, William C.; Bernardo, John; Moonan, Patrick K.; Mazurek, Gerald H.;
    Published:
    Jun 08 2011
    Source:
    PLoS One. 2011; 6(6).
    Description:
    Introduction : Interferon gamma (IFN-γ) release assays, such as QuantiFERON®-TB Gold test (QFT-G) and QuantiFERON®-TB Gold In-Tube test (QFT-GIT) are designed to detect M. tuberculosis (Mtb) infection. Recognition of unusual IFN-γ measurements ma...
    File Type:
    Filetype[PDF - 252.88 KB]
  5. Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence
    Personal Author:
    Lange, Christoph; Mandalakas, Anna M.; Kalsdorf, Barbara; Denkinger, Claudia M.; Sester, Martina;
    Published:
    Jan 04 2016
    Source:
    Pathog Immun. 1(2):308-329.
    Description:
    Despite global efforts to control tuberculosis (TB) the estimated number of people who developed TB worldwide increased to an all-time record of more than 10 million in 2015. The goal of the World Health Organization (WHO) to reduce the global incide...
    File Type:
    Filetype[PDF - 368.19 KB]